You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gsk1120212

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Chapel Hill (GSK1120212)

Completed
  • Breast Cancer
  • GSK1120212
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Sep 1, 2020

Advanced and Selected Solid Tumors Trial in Worldwide (BKM120, GSK1120212)

Completed
  • Advanced and Selected Solid Tumors
  • Los Angeles, California
  • +6 more
Dec 6, 2020

Cancer Trial in Australia, United States (GSK2118436, GSK1120212)

Completed
Has Results
  • Cancer
  • Los Angeles, California
  • +14 more
Jun 25, 2019

Cancer Trial in Worldwide (GSK1120212, Docetaxel + GSK1120212, Erlotinib + GSK1120212)

Terminated
Has Results
  • Cancer
  • GSK1120212
  • +7 more
  • Goodyear, Arizona
  • +18 more
Feb 17, 2019

Solid Tumors, Thyroid Cancer, Soft-tissue Sarcoma Trial in Baltimore, Houston (Pazopanib, GSK1120212)

Completed
  • Solid Tumors
  • +3 more
  • Baltimore, Maryland
  • +1 more
Aug 28, 2018

Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)

Completed
  • Cancer
  • Goodyear, Arizona
  • +43 more
Mar 20, 2019

Solid Tumours Trial in Osaka, Tokyo (GSK1120212, Gemcitabine)

Completed
  • Solid Tumours
  • Osaka, Japan
  • +1 more
Nov 8, 2017

Cancer Trial in Tacoma (GSK1120212, GSK1120212B)

Completed
  • Cancer
  • Tacoma, Washington
    GSK Investigational Site
Nov 8, 2017

GNA11 Mutation-positive Metastatic Melanoma, GNAQ Mutation-positive Metastatic Melanoma, Cancer Trial (GSK1120212)

Withdrawn
  • GNA11 Mutation-positive Metastatic Melanoma
  • +3 more
  • GSK1120212
  • (no location specified)
Dec 8, 2017

Cancer Trial in Tacoma (GSK1120212)

Completed
  • Cancer
  • GSK1120212
  • Tacoma, Washington
    GSK Investigational Site
Nov 8, 2017

Cancer Trial in Detroit, Nashville, San Antonio (GSK1120212)

Completed
  • Cancer
  • GSK1120212
  • Detroit, Michigan
  • +2 more
Nov 8, 2017

Leukaemia, Myelocytic, Acute Trial in Nashville, San Antonio (GSK1120212, Gemcitabine)

Completed
  • Leukaemia, Myelocytic, Acute
  • Nashville, Tennessee
  • +1 more
Nov 8, 2017

Cancer Trial in San Antonio, Salt Lake City (GSK1120212)

Completed
  • Cancer
  • GSK1120212
  • San Antonio, Texas
  • +1 more
Nov 8, 2017

Solid Tumours Trial in United States (GSK1120212)

Completed
  • Solid Tumours
  • GSK1120212
  • Scottsdale, Arizona
  • +11 more
Nov 8, 2017

Melanoma Trial in Worldwide (GSK1120212, Chemotherapy)

Completed
Has Results
  • Melanoma
  • Tucson, Arizona
  • +111 more
Mar 9, 2018

Cancer Trial in United States (GSK1120212, GSK2141795)

Completed
  • Cancer
  • Aurora, Colorado
  • +9 more
Nov 8, 2017

Cancer Trial in Dallas, San Antonio (GSK1120212, GSK2110183)

Completed
  • Cancer
  • Dallas, Texas
  • +1 more
Nov 8, 2017

Tumors, Oral, Mouth Tumors Trial in St. Louis (GSK1120212)

Completed
Has Results
  • Neoplasms, Oral
  • Mouth Neoplasms
  • GSK1120212
  • St. Louis, Missouri
    Washington University School of Medicine
Oct 31, 2016

Melanoma Trial in Houston (GSK2118436, GSK1120212)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 19, 2016

Lung Cancer, Non-Small Cell Trial in Worldwide (GSK1120212, docetaxel)

Completed
Has Results
  • Lung Cancer, Non-Small Cell
  • Scottsdale, Arizona
  • +59 more
Jun 26, 2014

Cancer Trial in Australia, United States (GSK1120212)

Completed
Has Results
  • Cancer
  • GSK1120212
  • Los Angeles, California
  • +9 more
Feb 13, 2014

Cancer Trial in Worldwide (GSK1120212)

Completed
Has Results
  • Cancer
  • GSK1120212
  • Birmingham, Alabama
  • +27 more
Mar 6, 2014

Cancer Trial in Korea, Republic of, Taiwan (GSK1120212, Gemcitabine, Placebo)

Completed
Has Results
  • Cancer
  • GSK1120212
  • +2 more
  • Seoul, Korea, Republic of
  • +6 more
Jul 25, 2013